Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chalcone synthase is an enzyme ubiquitous in higher plants and is the first committed step of the flavonoid biosynthetic pathway, catalyzing the conversion of 4-coumaroyl-CoA and three molecules of malonyl-CoA into naringenin chalcone, a key intermediate for the synthesis of many flavonoids and isoflavonoids[1][3][4][5]. CHS is classified as a type III polyketide synthase, operates as a homodimer, and is highly conserved across land plants[2][3][4]. Flavonoids produced via this pathway play key roles in pigmentation, protection against ultraviolet radiation, plant fertility, antifungal defense, and interactions with beneficial microbes[1][3]. CHS activity is tightly regulated by metabolic and transcriptional signals in plants[3]. It is widely studied for its role in plant biology, not as a pharmaceutical target, with notable scientific history including being the first gene in which RNA interference was described[3].
Not applicable in human drug context; catalyzes the condensation of 4-coumaroyl-CoA and three malonyl-CoA into naringenin chalcone in plants
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chalcone synthase (CHS).